@article{article, title  = {{019  Autologous stem cell transplantation versus alemtuzumab or ocrelizumab in relapsing remitting multiple sclerosis (StarMS)}},

 publisher = {{BMJ}},

 url = {{https://doi.org/10.1136/jnnp-2022-abn.58 }},

 year = {{2022}},

 month = {{5}},

 author = {{Sharrack B and Snowden J and Muraro P}},

 doi = {{10.1136/jnnp-2022-abn.58}},

 volume = {{93}},

 journal = {{Journal of Neurology, Neurosurgery & Psychiatry}},

 issue = {{6}},

 pages = {{A19.2-A19}},

 note = {{Accessed on 2025/11/15}}}